Valuation: Cencora, Inc.

Market Cap 56.12B 293B 49.27B 45.35B 42.26B 79.7B 5,335B 81.32B 545B 211B 2,619B 211B 206B 9,114B P/E 2026 *
15.9x
P/E 2027 * 17.1x
Enterprise Value 60.45B 315B 53.07B 48.85B 45.52B 85.85B 5,747B 87.6B 588B 228B 2,821B 227B 222B 9,818B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.17x
Free-Float
62.46%
Yield 2026 *
0.82%
Yield 2027 * 0.85%
1 day-0.32%
1 month-7.03%
3 months-24.59%
6 months-25.57%
Current year-25.57%
1 month 707.04
Extreme 707.04
709.32
Current year 665.32
Extreme 665.32
952.48
1 year 665.32
Extreme 665.32
960
3 years 430.43
Extreme 430.43
960
5 years 289.42
Extreme 289.42
960
10 years 181.9
Extreme 181.9
960
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-.--% - - 55.06B
+1.59%+1.87%-32.35%-15.45% 158B
+1.24%-1.16%-10.76%-10.10% 100B
-0.15%-0.90%+56.12%+49.58% 53.4B
+1.04%+3.47%-13.94%-42.09% 41.7B
+5.81%+15.76% - - 33.35B
+2.24%-1.28%-17.61%-46.42% 25.99B
+1.67%+7.22%+64.10%-4.57% 25.36B
+0.82%+2.48%-12.51%-5.64% 20.52B
+4.22%+2.58%-10.66%-1.62% 20.27B
Average +1.84%+3.20%+2.80%-9.54% 53.2B
Weighted average by Cap. +1.49%+2.07%-6.91%-9.05%

Financials

2026 *2027 *
Net sales 337B 1,758B 296B 273B 254B 479B 32,069B 489B 3,279B 1,270B 15,741B 1,266B 1,239B 54,784B 359B 1,871B 315B 290B 270B 510B 34,119B 520B 3,488B 1,352B 16,748B 1,347B 1,318B 58,286B
Net income 3.6B 18.78B 3.16B 2.91B 2.71B 5.12B 342B 5.22B 35.01B 13.57B 168B 13.52B 13.23B 585B 2.98B 15.54B 2.62B 2.41B 2.25B 4.24B 284B 4.32B 28.99B 11.23B 139B 11.2B 10.96B 484B
Net Debt 4.33B 22.59B 3.8B 3.5B 3.26B 6.15B 412B 6.28B 42.12B 16.32B 202B 16.27B 15.92B 704B 5.29B 27.59B 4.65B 4.28B 3.99B 7.52B 503B 7.67B 51.45B 19.93B 247B 19.87B 19.44B 860B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
288.42USD
Average target price
351.00USD
Spread / Average Target
+21.70%

Quarterly revenue - Rate of surprise